Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.

Abstract

BACKGROUND:

Hemorrhagic transformation (HT) is a critical issue in thrombolytic therapy in acute ischemic stroke. Damage-associated molecular pattern (DAMP)-stimulated sterile neuroinflammation plays a crucial role in the development of thrombolysis-associated HT. Our previous study showed that the phthalide derivative CD21 attenuated neuroinflammation and brain injury in rodent models of ischemic stroke. The present study explored the effects and underlying mechanism of action of CD21 on tissue plasminogen activator (tPA)-induced HT in a mouse model of transient middle cerebral artery occlusion (tMCAO) and cultured primary microglial cells.

METHODS:

The tMCAO model was induced by 2 h occlusion of the left middle cerebral artery with polylysine-coated sutures in wildtype (WT) mice and macrophage scavenger receptor 1 knockout (MSR1-/-) mice. At the onset of reperfusion, tPA (10 mg/kg) was intravenously administered within 30 min, followed by an intravenous injection of CD21 (13.79 mg/kg/day). Neuropathological changes were detected in mice 3 days after surgery. The effect of CD21 on phagocytosis of the DAMP peroxiredoxin 1 (Prx1) in lysosomes was observed in cultured primary microglial cells from brain tissues of WT and MSR1-/- mice.

RESULTS:

Seventy-two hours after brain ischemia, CD21 significantly attenuated neurobehavioral dysfunction and infarct volume. The tPA-infused group exhibited more severe brain dysfunction and hemorrhage. Compared with tPA alone, combined treatment with tPA and CD21 significantly attenuated ischemic brain injury and hemorrhage. Combined treatment significantly decreased Evans blue extravasation, matrix metalloproteinase 9 expression and activity, extracellular Prx1 content, proinflammatory cytokine mRNA levels, glial cells, and Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB) pathway activation and increased the expression of tight junction proteins (zonula occludens-1 and claudin-5), V-maf musculoaponeurotic fibrosarcoma oncogene homolog B, and MSR1. MSR1 knockout significantly abolished the protective effect of CD21 against tPA-induced HT in tMCAO mice. Moreover, the CD21-induced phagocytosis of Prx1 was MSR1-dependent in cultured primary microglial cells from WT and MSR1-/- mice, respectively.

CONCLUSION:

The phthalide derivative CD21 attenuated tPA-induced HT in acute ischemic stroke by promoting MSR1-induced DAMP (Prx1) clearance and inhibition of the TLR4/NF-κB pathway and neuroinflammation.

• Authors: Dong-Ling Liu, Zhi Hong, Jing-Ying Li, Yu-Xin Yang, Chu Chen, Jun-Rong Du
• Journal: Journal of neuroinflammation (J Neuroinflammation) Vol. 18 Issue 1 Pg. 143 (Jun 24 2021) ISSN: 1742-2094 [Electronic] England
• PMID: 34162400 (Publication Type: Journal Article)

Chemical References

• Benzofurans
• NF-kappa B
• Receptors, Scavenger
• Toll-Like Receptor 4
• phthalide derivative CD21
• Peroxiredoxins
• Tissue Plasminogen Activator

Topics

• Animals
• Benzofurans (pharmacology, therapeutic use)
• Brain (metabolism, pathology)
• Cell Line
• Cerebral Hemorrhage (drug therapy, metabolism, pathology)
• Disease Models, Animal
• Infarction, Middle Cerebral Artery
• Ischemic Stroke (drug therapy, pathology)
• Male
• Mice
• Mice, Inbred C57BL
• NF-kappa B (metabolism)
• Peroxiredoxins (metabolism)
• Receptors, Scavenger (metabolism)
• Reperfusion
• Tissue Plasminogen Activator (adverse effects)
• Toll-Like Receptor 4 (metabolism)